Henry Ford Hospital is an 877-bed tertiary care hospital, education and research complex at the western edge of the New Center area in Detroit, Michigan.

There are 877 beds in Henry Ford Health System - Hemophilia and Thrombosis Treatment Center.

During the past decade, Henry Ford Health System - Hemophilia and Thrombosis Treatment Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Henry Ford Health System - Hemophilia and Thrombosis Treatment Center" #1 collaborator was "CSL Behring" with 1 trials as a collaborator and "University of Pennsylvania" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Henry Ford Health System - Hemophilia and Thrombosis Treatment Center" are "Cirrhosis" (1 trials), "Hematological Malignancies" (1 trials), "Hemophilia A" (1 trials), "Hemophilia A, Congenital" (1 trials) and "Hemophilia B" (1 trials). Many other conditions were trialed in "Henry Ford Health System - Hemophilia and Thrombosis Treatment Center" in a lesser frequency.

Most popular intervention types in "Henry Ford Health System - Hemophilia and Thrombosis Treatment Center" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "KPG-818" (1 trials), "Kovaltry (Antihemophilic Factor [Recombinant], BAY81-8973" (1 trials), "Placebo" (1 trials) and "belapectin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Henry Ford Health System - Hemophilia and Thrombosis Treatment Center" are 2 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Henry Ford Health System - Hemophilia and Thrombosis Treatment Center". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Henry Ford Health System - Hemophilia and Thrombosis Treatment Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Henry Ford Health System - Hemophilia and Thrombosis Treatment Center, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".